March 16, 2026

Stryker Corporation (SYK) Stock Analysis: Evaluating a 26% Potential Upside in the Medical Device Sector

For investors navigating the healthcare sector, Stryker Corporation (NYSE: SYK) represents a compelling opportunity with a potential upside of over 26%, according to analyst ratings. As a significant player in..

Danaher Corporation (DHR) Stock Analysis: A 41% Upside Potential for Healthcare Investors

Investors looking to capitalize on the healthcare sector should certainly pay attention to Danaher Corporation (NYSE: DHR). With a substantial market capitalization of $132.46 billion, this Washington D.C.-based giant operates..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 45.82% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing investor attention with its substantial potential upside and a suite of strong buy ratings from analysts. This Utah-based healthcare company, specializing in..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring a Promising 55.92% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) has captured the attention of investors with its significant growth potential, underscored by a remarkable 55.92% potential upside, according to analyst ratings. As a healthcare..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 209.82% Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of novel cell therapies and an impressive potential upside of..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 24.72% Potential Upside Worth Watching

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, continues to capture investor attention with its robust pipeline of pharmaceutical products and a promising potential upside of..

Viatris Inc. (VTRS) Stock Analysis: Understanding the 14.73% Potential Upside for Investors

Viatris Inc. (VTRS), with its substantial market cap of $15.56 billion, is a noteworthy player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry. Headquartered in..

Repligen Corporation (RGEN) Stock Analysis: A Promising 62.63% Upside in the Bioprocessing Space

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, particularly in medical instruments and supplies, is poised for notable growth according to analysts. The company, renowned for its..

Guardant Health, Inc. (GH) Stock Analysis: A 55% Potential Upside Awaits in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the precision oncology space, is capturing investor attention with its innovative approach to cancer diagnostics and a compelling 55.07% potential upside. The..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a Potential 36.91% Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR) stands as a formidable entity within the healthcare sector, specifically in the niche of medical instruments and supplies. With a market capitalization of $5.41 billion, Avantor..

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with a 69.82% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a stalwart in the healthcare sector, specifically within the Medical Instruments & Supplies industry, presents a compelling investment opportunity with a robust potential upside of..

Bruker Corporation (BRKR): Investor Outlook Reveals 43% Potential Upside Amid Healthcare Sector Challenges

Investors eyeing the healthcare sector might find Bruker Corporation (BRKR) an intriguing opportunity, as the company showcases a potential upside of 43.49% based on analyst ratings. Bruker, a key player..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 42% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a prominent entity in the healthcare sector specializing in medical care facilities, is capturing investor attention with its impressive growth prospects and strong analyst consensus...

Regencell Bioscience Holdings (RGC) Stock Analysis: Unraveling the Prospects of a $11.49 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a healthcare entity based in Hong Kong, making strides in the specialized field of Traditional Chinese Medicine (TCM). With a market capitalization of..

Ionis Pharmaceuticals (IONS): Investor Outlook Reveals 31.90% Potential Upside Despite Challenging Metrics

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a prominent player in the biotechnology sector, with its focus on RNA-targeted medicines. Headquartered in Carlsbad, California, Ionis is currently valued at $11.76..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 13.28% Upside Potential

Biogen Inc. (BIIB), a stalwart in the healthcare sector, primarily engages in the discovery and development of therapies for a range of neurological and autoimmune conditions. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 24% Potential Upside

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, specializes in the development and supply of single-use medical devices. Headquartered in Wayne, Pennsylvania, Teleflex serves a global market..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Promising 17.93% Potential Upside in the Biotechnology Sector

Roivant Sciences Ltd. (NASDAQ: ROIV), a United Kingdom-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to drug discovery and development. Despite a challenging financial..

Ascendis Pharma A/S (ASND) Stock Analysis: A Promising 25% Upside Potential with Strong Buy Ratings

Investors with a keen eye on the biopharmaceutical sector should take a closer look at Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biotechnology powerhouse with a market capitalization of $13.87..

Zoetis Inc. (ZTS) Stock Analysis: Growth Potential with a 30.60% Upside for Animal Health Leader

Zoetis Inc. (NYSE: ZTS), a dominant player in the animal healthcare sector, presents an intriguing opportunity for investors seeking growth in a robust market. With a market capitalization of $50.95..

Search

Funds

March 16, 2026

Search

Funds

March 16, 2026

FTSE 100

Funds